| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1628208-23-0 | 4,7-Dihydro-6-(1-methylethyl)-7-oxo-5-phenylpyrazolo[1,5-a]pyrimidine-3-carbonitrile;CPI 455 | Csub16/subHsub14/subNsub4/subO |
| 1628260-79-6 | 2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)-5-thiazolecarbonitrile | Csub30/subHsub33/subFNsub8/subOsub2/subS |
| 1628265-17-7 | 2-Chloro-4-(4-fluorophenyl)thiazole-5-carbonitrile | Csub10/subHsub4/subClFNsub2/subS |
| 1628316-74-4 | 5-[[4-[[6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile;MI 136 | Csub23/subHsub21/subFsub3/subNsub6/subS |
| 1628317-18-9 | 4-Methyl-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile;MI 463 | Csub24/subHsub23/subFsub3/subNsub6/subS |
| 1628431-65-1 | 4-Amino-2-cyanobenzoic acid methyl ester | Csub9/subHsub8/subNsub2/subOsub2/sub |
| 1628639-06-4 | Olopatadine USP Related Compound A;Alpha-Hydroxy Olopatadine; (Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)-2-hydroxyacetic acid | Csub21/subHsub23/subNOsub4/sub |
| 1628732-62-6 | Olinciguat;(2R)-3,3,3-trifluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]amino]methyl]-2-hydroxypropanamide | Csub21/subHsub16/subFsub5/subNsub7/subOsub3/sub |
| 1628752-98-6 | 10-(4-(4,6-Diphenyl-1,3,5-triazin-2-yl)phenyl)-9,9-dimethyl-9,10-dihydroacridine;DMAC-TRZ | Csub36/subHsub28/subNsub4/sub |
| 1628790-37-3 | Cy5.5 alkyne;6-[1,1-dimethyl-2-[5-(1,1,3-trimethylbenzo[e]indol-3-ium-2-yl)penta-2,4-dienylidene]benzo[e]indol-3-yl]-N-prop-2-ynylhexanamide chloride | Csub43/subHsub46/subClNsub3/subO |
| 1628838-42-5 | N-[2-Methyl-5'-(4-morpholinyl)-6'-[(tetrahydro-2H-pyran-4-yl)oxy][3,3'-bipyridin]-5-yl]-3-(trifluoromethyl)benzamide | Csub28/subHsub29/subFsub3/subNsub4/subOsub4/sub |
| 1629229-37-3 | Fezolinetant;(4-fluorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone | Csub16/subHsub15/subFNsub6/subOS |
| 1629268-00-3 | 1-[3-[4-[2-[[4-Chloro-2-hydroxy-5-(1-methylcyclopropyl)phenyl]amino]acetyl]-1-piperazinyl]-1-azetidinyl]-2-propen-1-one;ARS 853 | Csub22/subHsub29/subClNsub4/subOsub3/sub |
| 1629618-98-9 | Trenbolone Enanthate;[(8S,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl] heptanoate | Csub25/subHsub34/subOsub3/sub |
| 1630193-77-9 | 2,5-Dimethoxypyridine-4-boronic acid | Csub7/subHsub10/subBNOsub4/sub |
| 1630815-44-9 | (3S,4R)-4-aminooxan-3-ol hydrochloride | Csub5/subHsub12/subClNOsub2/sub |
| 1630815-57-4 | N-[(3R,4S)-3-Fluoro-4-piperidinyl]carbamic acid 1,1-dimethylethyl ester | Csub10/subHsub19/subFNsub2/subOsub2/sub |
| 1630906-49-8 | N-[(3-Aminobicyclo[1.1.1]pent-1-yl)methyl]carbamic acid 1,1-dimethylethyl ester | Csub11/subHsub20/subNsub2/subOsub2/sub |
| 1630906-60-3 | 2,5-Diazaspiro[3.4]octane-5-carboxylic acid 1,1-dimethylethyl ester ethanedioate (2:1) | 2(Csub11/subHsub20/subNsub2/subOsub2/sub).Csub2/subHsub2/subOsub4/sub |
| 1631754-41-0 | Biafungin acetate;2-[[(3S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[4-(4-pentoxyphenyl)phenyl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-21-yl]oxy]ethyl-trimethylazanium;acetate | Csub65/subHsub88/subNsub8/subOsub19/sub |
| 1632032-53-1 | rel-(1R,4S)-3-[(4-Methyl-1-piperazinyl)carbonyl]-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid;LB 100 | Csub13/subHsub20/subNsub2/subOsub4/sub |
| 1632110-81-6 | (2S)-2-[1-(beta-D-Glucopyranosyloxy)-1-methylethyl]-2,3-dihydro-7-(hydroxymethyl)-4-methoxy-5H-furo[3,2-g][1]benzopyran-5-one | Csub22/subHsub28/subOsub11/sub |
| 1632118-69-4 | (3alpha,5beta,6beta,7beta)-6-Ethylcholane-3,7,24-triol | Csub26/subHsub46/subOsub3/sub |
| 1632118-70-7 | (3alpha,5beta,6beta,7alpha)-6-Ethylcholane-3,7,24-triol | Csub26/subHsub46/subOsub3/sub |
| 1632287-34-3 | Dapagliflozin MonoAcetyl Impurity;[(2R,3S,4R,5R,6S)-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-3,4,5-trihydroxyoxan-2-yl]methyl acetate | Csub23/subHsub27/subClOsub7/sub |
| 1632463-24-1 | 5-Chloro-N-[4-[(5S)-5-[[[(5-chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]-N-[2-[2-oxo-2-[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]amino]ethoxy]ethyl]-2-thiophenecarboxamide | Csub38/subHsub36/subClsub2/subNsub6/subOsub10/subSsub2/sub |
| 1632485-14-3 | 2,5-Dichloro-N-[2-[(1-methylethyl)thio]phenyl]-4-pyrimidinamine | Csub13/subHsub13/subClsub2/subNsub3/subS |
| 1633044-56-0 | N-[4-[[3-(3,5-Dimethoxyphenyl)-3,4-dihydro-7-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-2-oxopyrimido[4,5-d]pyrimidin-1(2H)-yl]methyl]phenyl]-2-propenamide;FIIN 2 | Csub35/subHsub38/subNsub8/subOsub4/sub |
| 1636130-32-9 | 1-(3-Bromo-5-(tert-butyl)phenyl)-1H-imidazole | Csub13/subHsub15/subBrNsub2/sub |
| 1637739-82-2 | 6-Amino-1,4-dihydro-1,3-dimethyl-4-[4-(trifluoromethyl)phenyl]pyrano[2,3-c]pyrazole-5-carbonitrile | Csub16/subHsub13/subFsub3/subNsub4/subO |
| 1637752-63-6 | 5-Phenyl-5,8-dihydroindolo[2,3-c]carbazole | Csub24/subHsub16/subNsub2/sub |
| 1638178-87-6 | Onc-206;11-benzyl-7-[(2,4-difluorophenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one | Csub23/subHsub22/subFsub2/subNsub4/subO |
| 1638250-96-0 | 1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-N-(6-phenyl-3-pyridazinyl)-7H-purine-7-acetamide | Csub19/subHsub17/subNsub7/subOsub3/sub |
| 1638329-59-5 | N-[2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide | Csub14/subHsub19/subBFNOsub3/sub |
| 1638744-12-3 | (1S)-2,2-difluorocyclohexan-1-amine hydrochloride | Csub6/subHsub12/subClFsub2/subN |
| 1638744-25-8 | (1S,3R)-(3-Hydroxy-cyclohexyl)-carbamic acid tert-butyl ester | Csub11/subHsub21/subNOsub3/sub |
| 1638744-85-0 | (1R)-2,2-Difluorocyclohexan-1-amine hydrochloride | Csub6/subHsub12/subClFsub2/subN |
| 1638744-86-1 | (3S,4R)-3-aminooxan-4-ol | Csub5/subHsub11/subNOsub2/sub |
| 1638759-62-2 | Tert-butyl 3,3-difluoro-2-(hydroxymethyl)azetidine-1-carboxylate | Csub9/subHsub15/subFsub2/subNOsub3/sub |
| 1638759-79-1 | 4-Bromo-1-methyl-1H-indazole-6-carboxylic acid methyl ester | Csub10/subHsub9/subBrNsub2/subOsub2/sub |
| 1638763-87-7 | 6-Chloro-1H-pyrrolo[2,3-b]pyridin-4-ol | Csub7/subHsub5/subClNsub2/subO |
| 1638767-25-5 | N-(3-Aminobicyclo[1.1.1]pent-1-yl)carbamic acid 1,1-dimethylethyl ester | Csub10/subHsub18/subNsub2/subOsub2/sub |
| 1638772-21-0 | 4-Bromo-2-methyl-2H-indazole-6-carboxylic acid methyl ester | Csub10/subHsub9/subBrNsub2/subOsub2/sub |
| 1639042-08-2 | (E)-3-[3,5-Difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]phenyl]acrylic acid | Csub25/subHsub25/subFsub3/subNsub2/subOsub2/sub |
| 1639263-80-1 | Vortioxetine Impurity 25;1-[2-(2,4-Dimethylphenyl)sulfonylphenyl]piperazine | Csub18/subHsub22/subNsub2/subOsub2/subS |
| 1639970-62-9 | Sacubitril Impurity 57;(2R,4s)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid | Csub22/subHsub23/subNOsub4/sub |
| 1640282-31-0 | 1-[7-(3,4-Dimethoxyphenyl)-2,3-dihydro-9-[[(3S)-1-methyl-3-piperidinyl]methoxy]-1,4-benzoxazepin-4(5H)-yl]-1-propanone;I-CBP 112 | Csub27/subHsub36/subNsub2/subOsub5/sub |
| 1640292-55-2 | trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide (2Z)-2-butenedioate (1:1) | Csub15/subHsub23/subNsub5/subOsub2/subS.Csub4/subHsub4/subOsub4/sub |
| 1640972-35-5 | Tofacitinib Impurity;3-[3-[6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl(methyl)amino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile | Csub16/subHsub22/subNsub6/subO |
| 1642288-47-8 | Mavacamten;(S)-3-Isopropyl-6-[(1-phenylethyl)amino]pyrimidine-2,4(1H,3H)-dione; 6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione | Csub15/subHsub19/subNsub3/subOsub2/sub |